0%
Stem Cell-Derived EV Characterization Solution

Stem Cell-Derived EV Characterization Solution

Stem Cell-Derived EV Characterization Solution

Background: Why SC-EV Characterization Matters

Stem cell-derived extracellular vesicles (SC-EVs) are promising cell-free therapeutics in regenerative medicine, enabling tissue repair, immune modulation, and treatment of aging-related diseases. By February 2026, their clinical use has extended to refractory conditions such as osteoarthritis, diabetic foot ulcers, and pulmonary fibrosis, with over 100 SC-EV trials registered on ClinicalTrials.gov — underscoring the urgency of clinical translation.

Precise characterization underpins the safety, efficacy, and standardized manufacturing of SC-EVs, yet progress is limited mainly by the lack of specific markers. Classical markers (CD9, CD63, CD81) are highly heterogeneous in SC-EVs and cannot reveal cellular origin. Defining SC-EV-specific marker profiles, building robust characterization technologies, and establishing a standardized “marker–function–quality” evaluation system are therefore central to clinical translation.

One Platform, Single-Particle, Multi-Parameter QC for Stem Cell EVs

  • SSEA4: a potential universal marker for PSC-EVs;
  • PODXL: an auxiliary specificity marker with pronounced cell line–specific expression.
  • Pinpointing tissue origin: CD13, CD29 and CD90 are abundantly expressed on MSC-sEVs and show strong source specificity;
  • Standardized quantification for quality control: >50% positivity across CD13, CD29 and CD90 defines MSC-EV identity, separating them from non-MSC EVs.
References
  1. Chen, Z., Luo, L., Ye, T., Zhou, J., Niu, X., Yuan, J., Yuan, T., Fu, D., Li, H., Li, Q., & Wang, Y. (2024). Identification of specific markers for human pluripotent stem cell-derived small extracellular vesicles. Journal of Extracellular Vesicles, 13, e12409.
  2. Luo, L., Chen, Z., Yuan, J., Niu, X., Liu, J., Gu, C., Xu, H., Jia, C., Na, T., Meng, S., Wang, Y., Li, H., & Li, Q. (2025). Identification of a specific marker panel for human mesenchymal stem cell-derived small extracellular vesicles. Interdisciplinary Medicine, 3, e70065.
  3. Li, M., Huang, H., Wei, X., Li, H., Li, J., Xie, B., Yang, Y., Fang, X., Wang, L., Zhang, X., Wang, H., Li, M., Lin, Y., Wang, D., Wang, Y., Zhao, T., Sheng, J., Hao, X., Yan, M., Xu, L., & Chang, Z. (2025). Clinical investigation on nebulized human umbilical cord MSC-derived extracellular vesicles for pulmonary fibrosis treatment. Signal Transduction and Targeted Therapy, 10, 179.